Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis. [PDF]
Nwozo E, Cross D, Smith D.
europepmc +1 more source
Can spesolimab cause acute pancreatitis?
No direct evidence for spesolimab causing acute pancreatitis. Indirect evidence from similar therapies suggests potential, warranting further investigation and vigilance in monitoring adverse effects.
openaire +1 more source
The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum. [PDF]
Gupta AK +5 more
europepmc +1 more source
Can spesolimab cause or aggravate an infection?
Evidence shows that spesolimab can increase the risk of infections, with significant incidence rates observed in clinical trials. Careful patient selection and monitoring are essential to mitigate this risk.
openaire +1 more source
Generalized Pustular Psoriasis: Current Treatment and Innovative Therapies. [PDF]
Martínez Villarreal JD +4 more
europepmc +1 more source
Breaking the barrier: oral tacrolimus plus apremilast rescues acute generalized pustular psoriasis with severe comorbidities-a case report. [PDF]
Tang L, He Y, Qiao Z, Zhou X, Hao P.
europepmc +1 more source
When Conventional Therapy Fails: Interleukin-36 Inhibition for Severe Hydroxychloroquine-Induced Acute Generalized Exanthematous Pustulosis in Systemic Lupus Erythematosus - A Case Report. [PDF]
Yang L +5 more
europepmc +1 more source
The Role of Genetic Testing in the Differential Diagnosis of Pustular Dermatoses: A Pediatric Case of Generalized Pustular Psoriasis Associated with the IL36RN Variant. [PDF]
Markwitz M +10 more
europepmc +1 more source
Sustained efficacy of spesolimab following flare-up dose in achieving long-term skin clearance in generalized pustular psoriasis: A case report and review of literature. [PDF]
Albadri AF +3 more
europepmc +1 more source
Spesolimab for treatment of severe hidradenitis suppurativa in the real world
Na, Wang +9 more
openaire +2 more sources

